Novel Early Phase Clinical Trial Design in Oncology Ciara O’BrienLouise CarterEmma Dean Review Article 27 September 2017 Pages: 297 - 307
First Amendment Protection of Evidence-Based Promotion of Prescription Drugs: A Study of Published Clinical Evidence Supporting Off-Label Promotion in the USA Jennifer L. HerbstVictoria E. RichardsAngela Mattie Original Research Article 17 August 2017 Pages: 309 - 315
Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks Makoto FujikawaShunsuke Ono Original Research Article Open access 13 July 2017 Pages: 317 - 327
Preferences for Receiving Results from a Rare Disease Clinical Trial: A Survey of Subjects with Friedreich’s Ataxia and their Parents Vincent AmelotCatherine BungenerIsabelle Husson Original Research Article 23 August 2017 Pages: 329 - 337
Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey Kimberly H. DavisAlex AsiimweElizabeth B. Andrews Original Research Article Open access 28 August 2017 Pages: 339 - 351